A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
Clinical trial NCT07137910 · RECRUITING
Trial details
- NCT number
- NCT07137910
- Sponsor
- Ausper Biopharma Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-04
- Primary completion
- 2026-12-12
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.